Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QAB149 water co-administration crossover study in asthma or COPD patients with prior cough
2004-004095-37Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of indacaterol in asthma and chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Novartis. Primary endpoints: Incidence of cough and Safety and tolerability. Started Dec 2004; status: completed.
02
Drugs
indacaterol
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2004-004095-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004095-37.